Related Experiment Videos

Superior mediastinal syndrome in an infant caused by mediastinal teratoma: case report

Jelena Roganovic1

  • 1Department of Pediatrics, Division of Hematology and Oncology, University Medical Center Rijeka, Croatia. jelena.roganovic@ri.htnet.hr

Tumori
|December 16, 2006
PubMed

Insights

A large mediastinal teratoma caused superior mediastinal syndrome in an infant, leading to severe cardiorespiratory distress. Prompt, multidisciplinary care is essential for managing these rare, life-threatening pediatric tumors.

Area of Science:

  • Pediatric Oncology
  • Thoracic Surgery
  • Medical Imaging

Background:

  • Mediastinal teratomas are germ cell tumors that can present in infants.
  • Superior mediastinal syndrome is a critical condition caused by compression of mediastinal structures.

Observation:

  • A 3-month-old male infant presented with symptoms of superior mediastinal syndrome.
  • Imaging revealed a large mediastinal mass consistent with a teratoma.

Findings:

  • The infant experienced severe cardiorespiratory compromise requiring immediate medical intervention.
  • Mediastinal teratomas in infancy pose significant life-threatening risks.

Implications:

  • Urgent, collaborative management involving pediatric oncologists, surgeons, anesthesiologists, intensivists, and radiologists is vital.
  • Early diagnosis and intervention are critical for improving outcomes in infants with mediastinal teratomas.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...